Form 4: Cryoport CEO Jerrell Shelton Reports Planned Stock Option Exercises and Share Sales

Cryoport, Inc. CEO and Director Jerrell Shelton reported the exercise of stock options and subsequent sale of shares, along with an additional option exercise, all executed under a pre-arranged trading plan.

Summary

• Jerrell Shelton, Cryoport's President, CEO, and Director, reported transactions involving the company's common stock.
• On June 24, 2025, Mr. Shelton acquired 16,344 shares of common stock by exercising stock options at an exercise price of $5.00 per share.
• Concurrently on June 24, 2025, he sold all 16,344 shares acquired from the option exercise at a weighted average price of $7.0586 per share, with individual sales ranging from $6.61 to $7.31.
• On June 25, 2025, Mr. Shelton acquired an additional 25,000 shares of common stock through a cash exercise of stock options at an exercise price of $5.00 per share, without a subsequent sale of these shares.
• All reported transactions were conducted automatically pursuant to a Rule 10b5-1 trading plan adopted on June 3, 2025.
• Following these transactions, Mr. Shelton's direct beneficial ownership of common stock is 937,419 shares.
• His remaining direct beneficial ownership of stock options (right to buy) is 125,000.

Sentiment

Score: 6

Explanation: The filing reports a planned exercise and sale of shares by the CEO, which is a routine event under a Rule 10b5-1 plan. The additional cash exercise of options without immediate sale could be seen as a minor positive, indicating continued holding of shares.

Positives

• The exercise of stock options by the CEO indicates a utilization of compensation benefits.
• The transactions were executed under a pre-arranged Rule 10b5-1 trading plan, which suggests a structured approach to managing equity and reduces concerns about opportunistic insider trading.
• The cash exercise of 25,000 options without immediate sale could be interpreted as a positive sign of continued confidence in the company's future by the CEO, as he is increasing his direct shareholding.

Negatives

• The sale of 16,344 shares by the CEO, even if pre-planned, represents a reduction in his direct equity stake in the company.
• The sale price of $7.0586 is relatively low compared to the potential for future growth, though it represents a profit over the $5.00 exercise price.

Management Comments

• "The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.61 to $7.31, inclusive."
• "This transaction involved a cash exercise of a stock option without a subsequent sale of the underlying shares of common stock."
• "This transaction occurred automatically pursuant to a trading plan adopted by the reporting person on June 3, 2025."
• "With respect to prices reported as weighted average prices in Table I, the reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the applicable footnotes to this Form 4."

Stakeholder Impact

• Shareholders: Provides transparency regarding insider stock transactions, which can influence investor sentiment. The sale of shares by a CEO, even if planned, might be viewed cautiously, while the exercise and retention of shares could be seen positively.

Next Steps

• The reporting person undertakes to provide full information regarding the number of shares sold at each separate price within the reported ranges upon request to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission.

Key Dates

Keywords

Cryoport, CYRX, Jerrell Shelton, SEC Form 4, Insider Trading, Stock Option Exercise, Share Sale, Rule 10b5-1 Plan, CEO, Director, Beneficial Ownership